Atlas Trials

Short-Term Oral Mifepristone for Central Serous Chorioretinopathy

Clinical trial NCT02354170 · COMPLETED

Trial details

NCT number
NCT02354170
Sponsor
Roger Goldberg, M.D., MBA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Central Serous Chorioretinopathy
Start date
2015-01-01
Primary completion
2017-04-27
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.